{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:01:29Z","timestamp":1694628089682},"reference-count":18,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Against 198 viridans group streptococci, 25\n            <jats:italic>Streptococcus bovis<\/jats:italic>\n            strains, and 5\n            <jats:italic>Cardiobacterium hominis<\/jats:italic>\n            strains, MICs of DX-619, a des-F(6)-quinolone, were between 0.004 and 0.25 \u03bcg\/ml. These MICs were lower than those of other quinolones (\u22640.008 to &gt;32 \u03bcg\/ml). \u03b2-Lactam MICs were between \u22640.008 and 16 \u03bcg\/ml. Azithromycin resistance was found in most species, while most were telithromycin susceptible. Glycopeptides and linezolid were active against viridans group strains but inactive against\n            <jats:italic>C. hominis<\/jats:italic>\n            .\n          <\/jats:p>","DOI":"10.1128\/aac.01110-06","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T19:39:16Z","timestamp":1164224356000},"page":"4191-4194","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Activity of DX-619 Compared to Other Agents against Viridans Group Streptococci,\n            <i>Streptococcus bovis<\/i>\n            , and\n            <i>Cardiobacterium hominis<\/i>"],"prefix":"10.1128","volume":"50","author":[{"given":"Klaudia","family":"Kosowska-Shick","sequence":"first","affiliation":[{"name":"Hershey Medical Center, Hershey, Pennsylvania 17033"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Smith","sequence":"additional","affiliation":[{"name":"Hershey Medical Center, Hershey, Pennsylvania 17033"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Bogdanovich","sequence":"additional","affiliation":[{"name":"Hershey Medical Center, Hershey, Pennsylvania 17033"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois M.","family":"Ednie","sequence":"additional","affiliation":[{"name":"Hershey Medical Center, Hershey, Pennsylvania 17033"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa 52317"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"Hershey Medical Center, Hershey, Pennsylvania 17033"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3325-3333.2005"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.8.2032"},{"key":"e_1_3_2_4_2","unstructured":"Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7 7th edition. Clinical and Laboratory Standards Institute Wayne Pa."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/dki404","volume":"57","year":"2006","unstructured":"Ergin, A., S. Ercis, and G. Hascelik. 2006. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans streptococci isolated from blood cultures. J. Antimicrob. Chemother.57:139-141.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.7.3040-3045.2005"},{"key":"e_1_3_2_7_2","first-page":"609","year":"2003","unstructured":"Graevenitz, A., R. Zbinden, and R. Mutters. 2003. Actinobacillus,Capnocytophaga,Eikenella,Kingella, and other fastidious or rarely encountered gram-negative rods, p. 609-622. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.","journal-title":"Manual of clinical microbiology"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.1.160-165.2006"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/314888"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.12.2760"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/jac\/45.6.771","volume":"45","year":"2000","unstructured":"Kaneko, A., J. Sasaki, M. Shimadzu, A. Kanayama, T. Saika, and I. Kobayashi. 2000. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci. J. Antimicrob. Chemother.45:771-775.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00165-5"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1887-1889.2006"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540510043266"},{"key":"e_1_3_2_15_2","first-page":"405","year":"2003","unstructured":"Ruoff, K. L., R. A. Whiley, and D. Beighton. 2003. Streptococcus, p. 405-421. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.","journal-title":"Manual of clinical microbiology"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki327"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(99)00172-7"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5051-5057.2005"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.11.2505"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01110-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01110-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:55:54Z","timestamp":1645469754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01110-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1128\/AAC.01110-06"],"URL":"https:\/\/doi.org\/10.1128\/aac.01110-06","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"2006-09-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-09-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}